Skip to main content

Advertisement

SpringerLink
Log in

Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer

  • Original Article
  • Published:
Tumor Biology

Abstract

Tumor necrosis factor receptor-associated protein 1 (TRAP1 or Hsp75) is a member of the mitochondrial heat shock proteins. TRAP1 expression is associated with drug and apoptosis resistance in various human cancers. This study assessed TRAP1 expression in tissue specimens of epithelial ovarian cancer (EOC) and its association with clinicopathological features and survival of EOC patients. Tissue samples from 356 patients were collected for immunohistochemical analysis of TRAP1 expression. TRAP1 levels in EOC tissues were significantly higher than that in noncancerous tissues. TRAP1 expression was associated with poor EOC differentiation, advanced pT stages, lymph node and distant metastasis, and advanced FIGO stages (p < 0.05). Kaplan-Meier survival analysis showed that TRAP1 expression was associated with poor prognosis of EOC patients and multivariate analysis revealed that TRAP1 expression (relative risk 6.720, CI 4.100–11.015, p < 0.001), tumor grade (p = 0.001), pathology stages (p = 0.001), and FIGO stage (p = 0.017) were all independent predictors of patients’ overall survival. These data demonstrate for the first time that increased TRAP1 expression was significantly associated with EOC stages and poor prognosis. Future studies are needed to confirm the role of TRAP1 as a prognostic tumor marker in EOC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Yan S, Deng Y, Qiang Y, et al. SYF2 is upregulated in human epithelial ovarian cancer and promotes cell proliferation. Tumor Biol. 2015;36:4633–42.

    Article  CAS  Google Scholar 

  2. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. Cancer statistics. CA Cancer J Clin. 2007;57:43–66.

    Article  PubMed  Google Scholar 

  3. Landen Jr CN, Birrer MJ, Sood AK, et al. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol. 2008;26:995–1005.

    Article  PubMed  Google Scholar 

  4. Landriscina M, Amoroso MR, Piscazzi A, Esposito F, et al. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol Oncol. 2010;117:177–82.

    Article  CAS  PubMed  Google Scholar 

  5. Hua G, Zhang Q, Fan Z, et al. Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J Biol Chem. 2012;282:20553–60.

    Article  Google Scholar 

  6. Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, Nakajo S, et al. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J Biol Chem. 2004;279:42503–15.

    Article  CAS  PubMed  Google Scholar 

  7. Montesano Gesualdi N, Chirico G, Pirozzi G, Costantino E, Landriscina M, Esposito F, et al. Tumor necrosis factor-associated protein 1(TRAP-1) protects cells from oxidative stress and apoptosis. Stress. 2007;10:342–50.

    Article  CAS  PubMed  Google Scholar 

  8. Xiang F, Huang YS, Shi XH, Zhang Q, et al. Mitochondrial chaperone tumour necrosis factor receptor-associated protein1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening. FEBS J. 2010;277:1929–38.

    Article  CAS  PubMed  Google Scholar 

  9. Tian X, Ma P, Sui C-G, et al. Suppression of TRAP1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cell. FEBS J. 2014;281(12):2805–19.

    Article  CAS  PubMed  Google Scholar 

  10. Agorreta J, Hu J, Liu D, et al. TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC. Mol Cancer Res. 2014;12(5):660–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ernst Justin T, Micheal L, Harmon Z, et al. Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases. Bioorg Med Chem Lett. 2014;24:204–8.

    Article  CAS  PubMed  Google Scholar 

  12. Maddalena F, Sisinni L, Lettini G, et al. Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1. Mol Oncol. 2013;7:895–906.

    Article  CAS  PubMed  Google Scholar 

  13. Altieri DC, Stein GS, Lian JB, Languino LR, Jordan SJ, Cushing-Haugen KL, et al. Breast-feeding and risk of epithelial ovarian cancer. Cancer Causes Control. 2012;23:919–27.

    Article  Google Scholar 

  14. Lee C, Park H-K, Jeong H, et al. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1. Am Chem Soc. 2015;137(13):4358–67.

    Article  CAS  Google Scholar 

  15. Qian H, Jing P, Weiping L, et al. Elevated cleaved caspase-3 is associated with shortened overall survival in several cancer types. Int J Clin Exp Pathol. 2014;7(8):5057–70.

    Google Scholar 

  16. Guzzo G, Sciacovelli M, Bernardi P. Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells. Oncotarget. 2014;5(23):11897–908.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Rasola A, Neckers L, Picard D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 2014;24(8):455–63.

    Article  CAS  PubMed  Google Scholar 

  18. Condelli V, Piscazzi A, Sisinni L. TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors. Cancer Res. 2014;74(22):6693–704.

    Article  CAS  PubMed  Google Scholar 

  19. Wertel I, Surówka J, Polak G, Barczyński B. Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients. Tumour Biol. 2015;36(6):4811–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dobrzycka B, Mackowiak-Matejczyk B, Terlikowska KM. Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma. Tumour Biol. 2015;36(6):4157–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ohkubo S, Kodama Y, Muraoka H. TAS-116, a highly selective inhibitor of heat shock protein 90α and β, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models. Mol Cancer Ther. 2015;14(1):14–22.

    Article  CAS  PubMed  Google Scholar 

  22. Kang BH, Plescia J, Dohi T, Rosa J, Doxsey SJ, Altieri DC, et al. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific HSP90 chaperone network. Cell. 2007;131:257–70.

    Article  CAS  PubMed  Google Scholar 

  23. Li S, Lv Q, Sun H, et al. Expression of TRAP1 predicts poor survival of malignant glioma patients. J Mol Neurosci. 2015;55(1):62–8.

    Article  PubMed  Google Scholar 

  24. Im C-N, Seo J-S, et al. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1), leads to mitochondrial aberrations in mouse fibroblast NIH/3T3 cells. BMB Rep. 2014;47(5):280–5.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Rota M, Pasquali E, Scotti L, Pelucchi C, Tramacere I, Islami F, et al. Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis. Gynecol Oncol. 2012;125:758–63.

    Article  CAS  PubMed  Google Scholar 

  26. Shen Y, Li DD, Wang LL, Deng R, et al. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy. 2008;4:1067–8.

    Article  CAS  PubMed  Google Scholar 

  27. Nguyen MC, Tu GH, Koprivnikar KE, Gonzalez-Edick M, et al. Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy. Cancer Immunol Immunother. 2010;59:1313–23.

    Article  CAS  PubMed  Google Scholar 

  28. Costantino E, Maddalena F, Calise S, Piscazzi A, Tirino V, Fersini A, et al. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptosis in human colorectal carcinoma cells. Cancer Lett. 2009;279:39–46.

    Article  CAS  PubMed  Google Scholar 

  29. Matassa DS, Agliarulo I, Amoroso MR, et al. TRAP1-dependent regulation of p70S6K is involved in the attenuation of protein synthesis and cell migration: relevance in human colorectal tumors. Mol Oncol. 2014;8(8):1482–94.

    Article  CAS  PubMed  Google Scholar 

  30. Amoroso MR, Matassa DS, Sisinni L, et al. TRAP1 revisited: novel localizations and functions of a ‘next-generation’ biomarker (review). Int J Oncol. 2014;45(3):969–77.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work is supported in part by grants from Liaoning Science and Technology Plan Projects (#2013225021), Shenyang Special Funds of Technology Innovation Plan Projects (#F14-231-1-46), and Liaoning Pacesetter Engineering Projects (#2011921040).

Author information

Authors and Affiliations

  1. Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, 110004, China

    Qingjie Lv, Hanxue Sun, Chengcheng Cao, Bo Gao & Yafei Qi

Authors
  1. Qingjie Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanxue Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chengcheng Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bo Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yafei Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qingjie Lv.

Ethics declarations

The described experiments comply with the current laws of China.

Conflicts of interest

None

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lv, Q., Sun, H., Cao, C. et al. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer. Tumor Biol. 37, 2721–2727 (2016). https://doi.org/10.1007/s13277-015-4112-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-4112-9

Keywords

Search

Navigation